Panel Discussion | Translating Learnings from IgA Nephropathy to Strive for Acceptable Surrogate Endpoints in Broader CKD

Time: 9:00 am
day: Conference Day 1


  • Debating whether hard outcome studies are needed to demonstrate meaningful changes in renal function
  • Extending the emerging learnings from IgA Nephropathy to other orphan kidney diseases
  • Debating the validity of surrogate endpoints for demonstrating renal function